1. The specificity of antibodies is very important for immunohistochenical analysis. The authors should confirm the specificity of TRIM59 antibodies to analyze human tissues. The authors showed that human cell lines such as PC3, LNCap and HEK293 express TRIM59 in a supplemental figure. The authors should perform immunocytochemical analysis and immunoblot analysis using TRIM59 knock-down cells (293, PC3 or LNCap) 
THE STUDY
The manuscript needs to more proofreading in order to be more readable. A quick look I see a few problems: 1. page 12, line 50, "was significantly"; 2. Page 18, line41, "may also possibly"; 3. Previously, the authors have reported that TRIM59 gene was upregulated in SV40 Tag oncogenedirected transgenic mouse prostate cancer models and that two phosphorylated forms of TRIM59 were observed by using purified TRIM59 proteins from mouse prostate cancer models at different stages. Furthermore, TRIM59 knockdown caused S-phase cell-cycle arrest and cell growth retardation. In this paper, the authors demonstrate that TRIM59 is highly expressed in several epithelial cancer tissues isolated from human samples and that TRIM59 may be used as a novel tumor marker for detecting early tumorigenesis. This manuscript contains some important issues, such as identification of high expression of TRIM59 in several cancer tissues including prostate, mammary gland, and so on. This paper might be of broad interest in the field of clinical oncology. The manuscript needs to more proofreading in order to be more readable. A quick look I see a few problems: 1. page 12, line 50, "was significantly"; 2. Page 18, line41, "may also possibly"; 3. page 16, line 26, "in m this"
Response: We have corrected all these mistakes.
1. The supplementary figure 1 is partially identical to a 2011 paper on Mol Cancer Ther title "Characterization of the Oncogenic Activity of the Novel TRIM59 Gene in Mouse Cancer Models". The author needs to point to the reference as the copyright of the figure must have been transferred to the journal.
